Advertisements



Johnson & Johnson Told to Pay $4.7 Billion in Talcum Powder Case - New York Times

New York TimesJohnson & Johnson Told to Pay $4.7 Billion in Talcum Powder CaseNew York TimesJohnson & Johnson was ordered Thursday to pay $4.69 billion to 22 women and thei.....»»

Category: topSource: googlenewsJul 12th, 2018

Johnson & Johnson told to pay $4.7 billion in talcum powder case

The company, maker of Johnson’s Baby Powder, said it was “deeply disappointed” in the verdict and planned to appeal......»»

Category: topSource: bizjournalsJul 13th, 2018

Jury awards nearly $4.7 billion in powder case

A St. Louis jury awarded nearly $4.7 billion in total damages to 22 women and their families after they claimed asbestos in Johnson & Johnson talcum powder contributed to their ovarian cancer. (July 13)       .....»»

Category: topSource: usatodayJul 13th, 2018

Jury Upholds $4.69B Verdict In Johnson & Johnson Baby Powder Case

A jury ruled against Johnson & Johnson (NYSE: JNJ) in which the health care giant attempted to reverse $4.14 billion in punitive damages and $550 million in compensatory damages. read more.....»»

Category: blogSource: benzingaDec 19th, 2018

J&J Slides After Failing To Overturn $4.7 Billion Talc Verdict

It's been a tough week for Johnson & Johnson, and it just got worse. The New York Times reports that J&J lost its motion on Wednesday to r.....»»

Category: blogSource: zerohedgeDec 19th, 2018

Johnson & Johnson has a good case to fight $4.7B baby powder lawsuit: Dr. Marc Siegel

Fox News medical correspondent Dr. Marc Siegel says Johnson & Johnson has a good case to fight the nearly $5 billion baby powder lawsuit......»»

Category: topSource: foxnewsJul 13th, 2018

J&J to pay $4.7 bln in cancer case

A Missouri jury ordered Johnson & Johnson to pay a record $4.7 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer. Fred Katayama reports......»»

Category: videoSource: reutersJul 13th, 2018

Johnson & Johnson is sliding after a jury awarded $4.69 billion to 22 women who said its talcum baby powder gave them cancer

AP Johnson & Johnson on Thursday was ordered to pay $4.69 billion to the 22 women who sai.....»»

Category: topSource: businessinsiderJul 13th, 2018

Jury orders J&J to pay $4.7 billion in Missouri asbestos cancer case

A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer......»»

Category: topSource: reutersJul 12th, 2018

St. Louis jury awards $550 million in talcum powder case

A St. Louis jury Thursday awarded $550 million in compensatory damages to 22 women who said Johnson & Johnson (NYSE: JNJ) talcum powder cased their ovarian cancer. The St. Louis Circuit Court jury unanimously decided to next consider punitive damages.....»»

Category: topSource: bizjournalsJul 12th, 2018

U.S. jury fails to reach verdict in latest J&J talc trial

NEW YORK (Reuters) - A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial......»»

Category: topSource: reutersMay 25th, 2018

U.S. jury fails to reach verdict in latest Johnson & Johnson talc trial over asbestos claims

NEW YORK (Reuters) - A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial......»»

Category: topSource: reutersMay 25th, 2018

J&J hit with $21.7 million verdict in another talc asbestos cancer case

NEW YORK (Reuters) - Johnson & Johnson and its talc suppliers on Wednesday were hit with a $21.7 million jury verdict in a lawsuit by a woman who said she developed cancer after being exposed to asbestos in the company's Baby Powder......»»

Category: topSource: reutersMay 23rd, 2018

Jury Awards $29 Million in Latest Johnson & Johnson Cancer-Causing Baby Powder Lawsuit

The lawsuit alleged that the company's talcum-based baby powder contained asbestos. An Oakland, Calif. jury has awarded a $29 million settlement to a woman who sued Johnson & Johnson over allegations that the compan.....»»

Category: europeSource: fortuneMar 15th, 2019

How Much More Talc Fallout Will Johnson & Johnson Face After This $29 Million Verdict?

Johnson & Johnson shares dipped on Thursday on news that a California jury awarded $29 million to a woman that claimed its talcum-powder-based products caused her cancer......»»

Category: blogSource: 247wallstMar 14th, 2019

Johnson & Johnson stock down after California jury awards $29M in baby powder cancer case

Johnson & Johnson must pay $29 million to a woman who claimed its baby powder gave her terminal cancer, a California.....»»

Category: topSource: usatodayMar 14th, 2019

California jury awards $29 million to woman with cancer who used J&J talc

A California jury on Wednesday awarded $29 million to a woman who said that asbestos in Johnson & Johnson's talcum-powder-based products caused her cancer......»»

Category: topSource: reutersMar 14th, 2019

California jury orders J&J to pay $29 million in latest talc cancer trial

A California jury on Wednesday ordered Johnson & Johnson to pay $29 million to a woman who said that asbestos in the company's talcum-powder-based products, including Johnson's Baby Powder, caused her mesothelioma......»»

Category: topSource: reutersMar 13th, 2019

Case of Mistaken Identity Sends Auris Medical Shares Soaring 30%

Auris Medical Holding AG got a surprise boost to its stock price Wednesday as investors mistakenly bought shares of the drug developer after Johnson & Johnson agreed to buy a similarly named robotics company for $3.4 billion......»»

Category: topSource: moneycentralFeb 13th, 2019

Penny Stock Auris Medical Spikes On Case Of Mistaken Identity

Auris Medical Holding AG (NASDAQ: EARS) stock traded higher by as much as 30 percent Wednesday morning after Johnson & Johnson (NYSE: JNJ) announced a $3.4 billion buyout of Auris Health. The only problem? read more.....»»

Category: blogSource: benzingaFeb 13th, 2019

Exclusive: Sri Lanka halts imports of Johnson & Johnson Baby Powder pending asbestos tests

Sri Lanka has halted imports of Johnson & Johnson Baby Powder until the company proves its product is free from cancer-causing asbestos, two government officials and the product's local distributor told Reuters......»»

Category: topSource: reutersJan 31st, 2019